BNP is well established and widely used clinically for diagnosis of heart disease especially heart failure; GDF15 was also recently proposed as an independent plasma biomarker for heart diseases (Wollert & Kempf, 2012; Baggen et al, 2017; Wollert et al, 2017). This evidence concerns the gene GDF15 and heart failure.